KFA Private Wealth Group’s West Pharmaceutical WST Stock Holding History

KFA Private Wealth Group’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$556K	Hold	1,500	–	–	0.13%	73
2026 Q2	$538K	Hold	1,500	–	–	0.13%	75
2026 Q1	$376K	Hold	1,500	–	–	0.09%	108
2025 Q4	$413K	Hold	1,500	–	–	0.1%	93
2025 Q3	$393K	Hold	1,500	–	–	0.11%	85
2025 Q2	$328K	Hold	1,500	–	–	0.1%	97
2025 Q1	$336K	Hold	1,500	–	–	0.12%	78
2024 Q4	$491K	Hold	1,500	–	–	0.21%	48
2024 Q3	$450K	Hold	1,500	–	–	0.21%	44
2024 Q2	$494K	Hold	1,500	–	–	0.26%	44
2024 Q1	$594K	Hold	1,500	–	–	0.18%	51
2023 Q4	$528K	Hold	1,500	–	–	0.19%	45
2023 Q3	$563K	Hold	1,500	–	–	0.23%	39
2023 Q2	$574K	Hold	1,500	–	–	0.24%	39
2023 Q1	$520K	Buy	+1,500	New	+$438K	0.24%	39

Other funds holding WST

Border to Coast Pensions Partnership Leeds, United Kingdom $7.27B AUM 24.98% 1-Year Est. Return

Birch Hill Investment Advisors Boston, Massachusetts $2.43B AUM 15.45% 1-Year Est. Return

Vest Financial Mclean, Virginia $9.5B AUM 22.78% 1-Year Est. Return

AMI Asset Management Los Angeles, California $1.74B AUM 24.77% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $45.5B AUM 15.2% 1-Year Est. Return

North Growth Management Vancouver, British Columbia, Canada $743M AUM 74.29% 1-Year Est. Return

AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

KFA Private Wealth Group's WST Position: Q3 2026 in Review

KFA Private Wealth Group held its West Pharmaceutical (WST) position steady in Q3 2026 at 1,500 shares worth $556K. The position accounts for 0.13% of the portfolio, ranked #73.

KFA Private Wealth Group first reported a position in WST in Q1 2023 and has held it in 15 quarters since. The position peaked at $594K in Q1 2024. 175 funds tracked by Wall St. Rank hold WST as of Q3 2026.

KFA Private Wealth Group held 1,500 shares of West Pharmaceutical worth $556K as of Q3 2026.
KFA Private Wealth Group left its West Pharmaceutical share count unchanged in Q3 2026.
West Pharmaceutical made up 0.13% of KFA Private Wealth Group's portfolio in Q3 2026, its #73 holding.
KFA Private Wealth Group first reported a position in West Pharmaceutical in Q1 2023 and has held it in 15 quarters since.
KFA Private Wealth Group's West Pharmaceutical position peaked at $594K in Q1 2024.
175 funds tracked by Wall St. Rank held West Pharmaceutical as of Q3 2026.

Based on KFA Private Wealth Group's 13F filing for Q3 2026, filed 7 Oct 2026.